Big compensation, mild mergers, a Kite in an updraft, and tightening the biotech belt Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesGinkgoEagle + AcaciaGileadTaysha/Orchard/SilverbackAbout the ShowLife Science Today…
$2 billion in capital raises mostly by companies that start with the letter A. Find out more athttps://LifeScienceTodayPodcast.comStory References2seventy BioAscendisApellisArgenxAbout the ShowLife Science Today is your…
Case closed on patents, Alzheimer’s data, generic approvals, and expanded approvals. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlexion + ChugaiBiogenViatrisAbbVieAbout the ShowLife Science Today is your…
Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesGileadAstraZeneca + Merck + MyriadDNAnexus About the ShowLife Science…
Who owns CRISPR, a collaboration, the classics, and more money for biotech. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesSanofi + AdageneAbbVie + SyndesiAtlasAbout the ShowLife Science Today…
CRISPR works, the opioid epidemic makes amends (sort of), and the SPAC that wasn’t Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesIntelliaPurdue PharmaAmicus SPACAbout the ShowLife Science Today…
The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesEli Lilly + Innovent BiologicsAgiosTC BiopharmBlue…
Dragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesArcellxIntellia + RewriteNavitor + JanssenViiV About the ShowLife Science Today…
Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetime Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesGenentechImmunocoreBiogenEli LillyTenSixteen About the ShowLife Science Today…
Psychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesEleusisAbbvie/Pfizer/LeoUCB + ZogenixKuraGSK – UnileverAbout…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
